Lisinopril kidney
Pro Research Analysisby 
Searched over 200M research papers for "lisinopril kidney"
Lisinopril and Kidney Function: A Comprehensive Review
Introduction to Lisinopril and Kidney Health
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is widely used to manage hypertension and heart failure. Its impact on kidney function, particularly in patients with diabetic nephropathy and other renal conditions, has been extensively studied. This article synthesizes findings from multiple research studies to provide a clear understanding of how lisinopril affects kidney health.
Lisinopril in Diabetic Nephropathy
Comparative Studies with Atenolol
Several studies have compared the effects of lisinopril with other antihypertensive agents like atenolol in patients with diabetic nephropathy. One study involving hypertensive non-insulin-dependent diabetes mellitus (NIDDM) patients found that both lisinopril and atenolol effectively reduced blood pressure and slowed the decline in glomerular filtration rate (GFR) over a 42-month period. However, lisinopril was more effective in reducing urinary albumin excretion, a key marker of kidney damage, by 55% compared to 15% with atenolol Nielsen1997Nielsen1994.
Long-Term Effects and Renoprotection
In a four-year study comparing lisinopril with the calcium antagonist nisoldipine, both drugs showed similar benefits in slowing the progression of diabetic nephropathy. However, lisinopril significantly reduced albuminuria, indicating better renoprotective effects . Another study highlighted that lisinopril, when used in combination with losartan, did not provide additional benefits and increased the risk of adverse events such as hyperkalemia and acute kidney injury .
Lisinopril in Non-Diabetic Nephropathies
Proteinuria and Renal Function
Lisinopril has also been studied in patients with non-diabetic chronic renal diseases. In a study involving patients with mild proteinuria, lisinopril was more effective than other antihypertensive agents in slowing the progression of renal insufficiency. The study found that patients treated with lisinopril had a significantly slower decline in renal function compared to those on alternative therapies .
Genetic Factors and Lisinopril Efficacy
ACE Gene Polymorphism
The effectiveness of lisinopril can be influenced by genetic factors. A study on insulin-dependent diabetes mellitus (IDDM) patients found that the ACE gene insertion/deletion polymorphism modulates the progression of renal disease and the response to ACE inhibitors. Patients with the II genotype showed the fastest rate of albumin excretion rate (AER) progression on placebo but had an enhanced response to lisinopril, with a 51.3% reduction in AER compared to placebo .
Lisinopril and Kidney Injury
Protective Effects Against Acute Kidney Injury
Lisinopril has shown potential in protecting against acute kidney injury (AKI) induced by nephrotoxic agents like doxorubicin. In a study on male Wistar rats, lisinopril significantly reduced markers of kidney damage such as serum creatinine, blood urea nitrogen (BUN), and kidney injury molecule-1 (KIM-1) levels. This suggests that lisinopril may have antioxidant properties that help mitigate kidney injury .
Conclusion
Lisinopril is a potent ACE inhibitor with significant benefits for kidney health, particularly in patients with diabetic nephropathy and mild proteinuric non-diabetic nephropathies. It effectively reduces albuminuria and slows the progression of renal disease. However, its efficacy can be influenced by genetic factors, and combination therapy with other antihypertensive agents may increase the risk of adverse events. Overall, lisinopril remains a valuable option for protecting kidney function in various patient populations.
Sources and full results
Most relevant research papers on this topic
Impact of Lisinopril and Atenolol on Kidney Function in Hypertensive NIDDM Subjects With Diabetic Nephropathy
Lisinopril effectively reduces albuminuria more than atenolol in hypertensive NIDDM patients with diabetic nephropathy, potentially improving kidney function.
Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.
Both lisinopril and nisoldipine have similar long-term renoprotective effects in hypertensive type 1 diabetic patients with diabetic nephropathy.
Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies.
Lisinopril has a specific renoprotective effect in addition to blood pressure control in patients with mild proteinuria, slowing the progression of non-diabetic chronic renal diseases.
DOI